# Pennant Group, Inc.: filings

PNTG · Nasdaq · CIK 1766400 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/pntg.md) · [Financials](/companies/pntg/financials.md) · [Filings](/companies/pntg/filings.md) · [Insiders](/companies/pntg/insiders.md)

## Reports and events: 97 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 300, 8-K 60, SC 13G/A 25, 144 24, 10-Q 21, 3 16, SCHEDULE 13G/A 10, UPLOAD 10, 4/A 8, CORRESP 8, 10-K 7, DEF 14A 7, SC 13G 7, 5 6, 10-12B/A 3, SCHEDULE 13G 3, 424B5 2, 8-K/A 2, DEFA14A 2, S-8 2, 10-12B 1, CERT 1, DRS 1, DRS/A 1, DRSLTR 1, PRE 14A 1, S-3ASR 1, SEC STAFF ACTION 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-05 | 16:20 ET | [10-Q](/filings/0001766400-26-000065.md) | Quarterly report, period 2026-06-30 | 0001766400-26-000065 |
| 2026-08-05 | 16:16 ET | [8-K](/filings/0001766400-26-000064.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001766400-26-000064 |
| 2026-05-20 | 16:02 ET | [8-K](/filings/0001766400-26-000056.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001766400-26-000056 |
| 2026-05-06 | 16:09 ET | [10-Q](/filings/0001766400-26-000054.md) | Quarterly report, period 2026-03-31 | 0001766400-26-000054 |
| 2026-05-06 | 16:07 ET | [8-K](/filings/0001766400-26-000053.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001766400-26-000053 |
| 2026-03-31 | 16:05 ET | [DEF 14A](/filings/0001766400-26-000027.md) | Proxy statement, period 2026-05-14 | 0001766400-26-000027 |
| 2026-02-26 | 08:05 ET | [10-K](/filings/0001766400-26-000014.md) | Annual report, period 2025-12-31 | 0001766400-26-000014 |
| 2026-02-25 | 16:25 ET | [8-K](/filings/0001766400-26-000011.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001766400-26-000011 |
| 2025-12-17 | 19:02 ET | [8-K/A](/filings/0001766400-25-000147.md) | 9.01 Financial statements and exhibits | 0001766400-25-000147 |
| 2025-11-05 | 16:32 ET | [8-K](/filings/0001766400-25-000141.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001766400-25-000141 |
| 2025-11-05 | 16:15 ET | [10-Q](/filings/0001766400-25-000139.md) | Quarterly report, period 2025-09-30 | 0001766400-25-000139 |
| 2025-11-05 | 16:09 ET | [8-K](/filings/0001766400-25-000137.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001766400-25-000137 |
| 2025-10-02 | 14:52 ET | [8-K/A](/filings/0001766400-25-000116.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001766400-25-000116 |
| 2025-10-02 | 18:39 ET | [8-K](/filings/0001766400-25-000114.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001766400-25-000114 |
| 2025-10-02 | 18:39 ET | [8-K](/filings/0001766400-25-000113.md) | 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001766400-25-000113 |
| 2025-08-06 | 16:11 ET | [10-Q](/filings/0001766400-25-000103.md) | Quarterly report, period 2025-06-30 | 0001766400-25-000103 |
| 2025-08-06 | 16:08 ET | [8-K](/filings/0001766400-25-000102.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001766400-25-000102 |
| 2025-05-20 | 16:08 ET | [8-K](/filings/0001766400-25-000071.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001766400-25-000071 |
| 2025-05-06 | 16:12 ET | [10-Q](/filings/0001766400-25-000069.md) | Quarterly report, period 2025-03-31 | 0001766400-25-000069 |
| 2025-05-06 | 16:10 ET | [8-K](/filings/0001766400-25-000068.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001766400-25-000068 |
| 2025-05-01 | 17:02 ET | [8-K](/filings/0001766400-25-000056.md) | 1.01 Entry into a material agreement | 0001766400-25-000056 |
| 2025-04-17 | 16:09 ET | [DEF 14A](/filings/0001766400-25-000038.md) | Proxy statement, period 2025-05-16 | 0001766400-25-000038 |
| 2025-02-27 | 16:09 ET | [8-K](/filings/0001766400-25-000025.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001766400-25-000025 |
| 2025-02-27 | 16:08 ET | [10-K](/filings/0001766400-25-000024.md) | Annual report, period 2024-12-31 | 0001766400-25-000024 |
| 2025-01-02 | 16:07 ET | [8-K](/filings/0001766400-25-000003.md) | 2.01 Completion of an acquisition or disposition | 0001766400-25-000003 |
| 2024-11-06 | 16:14 ET | [10-Q](/filings/0001766400-24-000128.md) | Quarterly report, period 2024-09-30 | 0001766400-24-000128 |
| 2024-11-06 | 16:14 ET | [8-K](/filings/0001766400-24-000127.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001766400-24-000127 |
| 2024-10-04 | 16:08 ET | [8-K](/filings/0001766400-24-000104.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001766400-24-000104 |
| 2024-08-06 | 16:09 ET | [10-Q](/filings/0001766400-24-000096.md) | Quarterly report, period 2024-06-30 | 0001766400-24-000096 |
| 2024-08-06 | 16:08 ET | [8-K](/filings/0001766400-24-000095.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001766400-24-000095 |
| 2024-08-01 | 16:20 ET | [8-K](/filings/0001766400-24-000090.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001766400-24-000090 |
| 2024-07-11 | 12:25 ET | [8-K](/filings/0001766400-24-000070.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001766400-24-000070 |
| 2024-05-29 | 11:39 ET | [8-K](/filings/0001766400-24-000063.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001766400-24-000063 |
| 2024-05-06 | 16:09 ET | [10-Q](/filings/0001766400-24-000056.md) | Quarterly report, period 2024-03-31 | 0001766400-24-000056 |
| 2024-05-06 | 16:07 ET | [8-K](/filings/0001766400-24-000055.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure | 0001766400-24-000055 |
| 2024-04-11 | 16:06 ET | [DEF 14A](/filings/0001766400-24-000036.md) | Proxy statement, period 2023-12-31 | 0001766400-24-000036 |
| 2024-03-12 | 12:49 ET | [8-K](/filings/0001766400-24-000031.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001766400-24-000031 |
| 2024-02-28 | 16:16 ET | [10-K](/filings/0001766400-24-000022.md) | Annual report, period 2023-12-31 | 0001766400-24-000022 |
| 2024-02-28 | 16:13 ET | [8-K](/filings/0001766400-24-000020.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001766400-24-000020 |
| 2023-11-07 | 16:12 ET | [10-Q](/filings/0001766400-23-000127.md) | Quarterly report, period 2023-09-30 | 0001766400-23-000127 |
| 2023-11-07 | 16:11 ET | [8-K](/filings/0001766400-23-000126.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001766400-23-000126 |
| 2023-08-08 | 16:08 ET | [10-Q](/filings/0001766400-23-000095.md) | Quarterly report, period 2023-06-30 | 0001766400-23-000095 |
| 2023-08-08 | 16:06 ET | [8-K](/filings/0001766400-23-000094.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001766400-23-000094 |
| 2023-06-12 | 16:06 ET | [8-K](/filings/0001766400-23-000073.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001766400-23-000073 |
| 2023-05-25 | 16:09 ET | [8-K](/filings/0001766400-23-000068.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001766400-23-000068 |
| 2023-05-22 | 16:09 ET | [8-K](/filings/0001766400-23-000066.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001766400-23-000066 |
| 2023-05-04 | 16:09 ET | [10-Q](/filings/0001766400-23-000061.md) | Quarterly report, period 2023-03-31 | 0001766400-23-000061 |
| 2023-05-04 | 16:08 ET | [8-K](/filings/0001766400-23-000060.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001766400-23-000060 |
| 2023-04-13 | 16:07 ET | [DEF 14A](/filings/0001766400-23-000041.md) | Proxy statement | 0001766400-23-000041 |
| 2023-02-28 | 16:09 ET | [8-K](/filings/0001766400-23-000028.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001766400-23-000028 |

Page 1 of 2. [Older](/companies/pntg/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 12:38 ET. No prices; not investment advice.